
|Podcasts|November 1, 2021
What does the BCG shortage look like in 2021?
Author(s)Urology Times staff
“I wouldn't be surprised if we have spotty distribution areas of concern for the next several years,” says Sam S. Chang MD, MBA, on the latest episode of the UT podcast Speaking of Urology.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Sam S. Chang, MD, MBA. He discusses the current state of the BCG shortage, what is being done to resolve it, and what the future holds for patients with non–muscle-invasive bladder cancer who are seeking treatment. Chang is a Patricia and Rodes Hart professor of urology and oncology at the Vanderbilt University Medical Center and chief surgical officer at the Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
2
Jessica Yih, MD, highlights data on testosterone therapy in women
3
Blue light cystoscopy is tied to higher resource use, not health care cost, in NMIBC
4
The AUA Clinically Localized Prostate Cancer guideline: FAQs for urologists
5






